No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1544 |
4. Check minimum number of eventsNone |
1544 |
5. Include endpointsNone |
1544 |
6. Filter based on genotype QC (FinnGen only) |
1544 |
Control definitions (FinnGen only)
- Control exclude
- H8_INNER
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H83
- Name in latin
- Laesio auris internae e strepitu
Similar endpoints
↥List of similar endpoints to
Noise effects on inner ear
based on the number of shared cases.
Similar with more cases:
- Diseases of inner ear
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13487 | 861 | 12565 |
| Only index persons | 12716 | 844 | 11872 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.33 | 0.02 | 0.35 |
| Only index persons | 0.43 | 0.03 | 0.45 |
| Median age at first event (years) | |||
| Whole population | 53.71 | 51.05 | 53.80 |
| Only index persons | 52.85 | 51.01 | 52.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1544 | 131 | 1413 |
| Unadjusted period prevalence (%) | 0.57 | 0.04 | 0.62 |
| Median age at first event (years) | 56.33 | 47.34 | 57.16 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1365
- Matched controls
- 13650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H83.3
ICD-10 Finland
Noise effects on inner ear
10704.9
323.0
1300
20
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
9.3
261.1
658
1237
Z01.1
ICD-10 Finland
Examination of ears and hearing
5.6
112.1
373
852
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
8.3
110.3
264
383
DFF00
NOMESCO Finland
Pure tone audiometry
5.8
85.3
265
540
3881A
ICD-9 Finland
Other disorders of ear, Noise effects on inner ear
+∞
67.2
64
*
Z57.0
ICD-10 Finland
Occupational exposure to noise
332.0
64.0
64
*
DFF15
NOMESCO Finland
Speech audiometry
7.4
59.7
150
225
Z97.4
ICD-10 Finland
Presence of external hearing-aid
6.7
59.5
160
264
UDC00
NOMESCO Finland
Ear microscopy
5.1
58.2
198
437
H93.1
ICD-10 Finland
Tinnitus
4.9
50.5
179
410
W34
ICD-10 Finland
Discharge from other and unspecified firearms
216.4
41.1
42
*
DAX08
NOMESCO Finland
Fitting of hearing aid
5.8
38.0
112
206
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
5.3
33.6
107
216
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
6.2
32.0
89
152
W42
ICD-10 Finland
Exposure to noise
168.9
31.8
33
*
W3388
ICD-10 Finland
NA
+∞
29.3
28
*
H02
ICPC
Hearing complaint
2.8
27.8
193
752
N07CA01
ATC
betahistine; oral
3.8
27.2
122
345
SPAT1043
SPAT
Audiometry
2.9
26.2
171
638
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
5.9
24.6
70
124
H91.9
ICD-10 Finland
Hearing loss, unspecified
4.4
22.7
84
199
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
18.4
198
966
R5120
NOMESCO Finland
Preparation of an aid
4.7
15.5
53
117
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
3.5
13.8
64
188
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
8.9
13.0
27
31
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.6
12.8
92
364
ZXE10
NOMESCO Finland
More than one and less than three hours
0.6
12.6
201
3144
M03BX02
ATC
tizanidine; oral
1.5
12.5
736
5947
H29
ICPC
Ear symptom/complaint other
2.3
12.5
123
570
R5140
NOMESCO Finland
Monitoring the use of the aid
2.0
12.5
172
923
WX704
NOMESCO Finland
Intubation
2.4
11.9
104
457
T70.0
ICD-10 Finland
Otitic barotrauma
121.0
11.4
12
*
ZXD10
NOMESCO Finland
Scheduled procedure
0.6
11.0
218
3258
H81.3
ICD-10 Finland
Other peripheral vertigo
8.6
10.5
22
26
H91.1
ICD-10 Finland
Presbycusis
2.6
10.5
74
291
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
10.1
64
237
H81.0
ICD-10 Finland
Ménière disease
16.8
9.9
15
9
WX720
NOMESCO Finland
Own respiration
2.7
9.7
65
247
ZXE00
NOMESCO Finland
One hour or less
0.6
9.6
238
3398
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.2
9.5
98
469
N02BE01
ATC
paracetamol; systemic, rectal
1.5
9.4
1046
9359
H03
ICPC
Tinnitus, ringing/buzzing ear
3.8
9.3
38
102
SPAT1263
SPAT
Sampling
1.5
9.3
468
3582
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
9.2
286
1967
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
9.2
217
1390
R42
ICD-10 Finland
Dizziness and giddiness
1.7
9.0
200
1258
M02AA10
ATC
ketoprofen; topical
1.8
9.0
172
1033
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
8.9
805
6870
L13
ICPC
Hip symptom/complaint
1.9
8.8
138
776
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
8.5
604
4917
N03AX12
ATC
gabapentin; oral
1.7
8.5
163
982
Z2221
NOMESCO Finland
Medical doctor
0.6
8.5
139
2186
WX419
NOMESCO Finland
Other general anesthesy
6.7
8.4
20
30
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
8.2
1121
10267
L08
ICPC
Shoulder symptom/complaint
1.6
8.1
205
1333
Y89.1
ICD-10 Finland
Sequelae of war operations
22.2
8.0
11
5
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
8.0
442
3427
R05
ICPC
Cough
1.6
7.8
206
1358
Z3231
NOMESCO Finland
Registered nurse
0.6
7.7
158
2369
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.1
7.7
86
426
H81.2
ICD-10 Finland
Vestibular neuronitis
45.2
7.7
9
*
T15.0
ICD-10 Finland
Foreign body in cornea
2.2
7.6
73
337
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
2.7
7.5
50
193
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
7.5
426
3309
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
7.4
295
2135
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
7.3
64
286
M01AH05
ATC
etoricoxib; oral
1.4
7.3
670
5652
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
7.0
191
1267
M01AB05
ATC
diclofenac; systemic, rectal
1.4
6.8
798
6963
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.8
236
1660
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.7
6.7
145
906
L15
ICPC
Knee symptom/complaint
1.6
6.6
193
1302
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.5
524
4302
A02BC03
ATC
lansoprazole; oral
1.4
6.4
302
2259
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
6.3
235
1675
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.3
400
3154
R4110
NOMESCO Finland
Physiotherapy
0.6
6.3
148
2158
KMAK
NOMESCO Finland
NA
1.3
6.2
575
4815
M01AX05
ATC
glucosamine; oral
1.6
6.2
176
1180
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
6.1
450
3636
M54.2
ICD-10 Finland
Cervicalgia
2.0
6.0
69
348
L01
ICPC
Neck symptom/complaint
1.7
6.0
119
725
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
260
1441
1.97
19.95
5.0
4.5
%
31.8
30.6
1.05
192
995
(3047181) Lactate [Moles/volume] in Blood
111
452
2.57
18.03
6.6
7.4
mmol/l
1.3
1.4
0.51
103
391
(3021589) Normoblasts [#/volume] in Blood
368
5348
0.59
16.86
9.3
10.0
e9/l
0.0
0.0
0.71
313
4398
(3018572) Chloride [Moles/volume] in Blood
88
337
2.71
16.17
7.1
8.3
mmol/l
104.4
105.7
1.24
82
296
(3039000) Anion gap in Blood
88
337
2.71
16.17
7.1
8.3
mmol/l
11.6
11.5
0.08
82
296
(3017732) Neutrophils [#/volume] in Blood
151
788
2.02
13.55
2.9
3.3
e9/l
4.1
4.1
0.10
125
620
(3019150) Specific gravity of Urine by Refractometry
366
2531
1.58
12.37
3.5
3.5
kg/l
1.0
1.0
0.06
95
351
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
116
583
2.07
11.53
6.0
6.2
%
2.0
1.7
1.05
108
538
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1337
12250
1.68
10.86
4.6
4.4
mmol/l
1.3
1.3
0.26
1263
11361
(3022621) pH of Urine by Test strip
130
698
1.94
10.74
3.3
2.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1360
12528
1.72
10.69
5.0
4.9
mmol/l
2.8
2.7
1.45
1283
11616
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1342
12335
1.67
10.43
4.7
4.5
mmol/l
4.5
4.5
0.80
1270
11513
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
99
488
2.10
10.37
2.2
1.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
111
577
2.00
10.07
6.3
6.2
%
1.0
0.9
4.82
104
535
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
501
3849
1.45
9.88
3.1
2.7
u/l
58.2
58.2
0.00
468
3598
(3019225) pH of Specimen
182
1120
1.71
9.62
3.7
4.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1294
11845
1.57
9.57
4.9
4.5
mmol/l
6.0
6.1
3.72
1212
10868
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1407
13163
1.78
9.43
10.1
10.5
u/l
30.6
30.7
0.08
1376
12749
(3030467) Casts [#/volume] in Urine by Automated count
244
3516
0.64
9.40
3.3
3.3
e6/l
0.3
0.4
0.55
200
2713
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1296
11896
1.56
9.16
4.1
4.0
mmol/l
1.4
1.4
0.31
1226
10990
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
119
2031
0.55
8.97
2.8
3.3
mmol/l
2.4
2.4
2.23
107
1788
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
56
234
2.45
8.71
1.6
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
59
254
2.38
8.61
1.2
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
99
523
1.95
8.60
4.2
4.1
mmol/l
25.1
24.8
0.47
91
492
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
945
8255
1.37
8.16
5.0
4.7
ug/l
3.1
2.5
0.27
887
7457
(3024731) MCV [Entitic volume]
1445
13727
1.82
7.77
21.2
21.5
fl
90.9
91.1
1.05
1435
13543
(3026361) Erythrocytes [#/volume] in Blood
1445
13728
1.82
7.75
21.3
21.6
e12/l
4.7
4.6
0.80
1422
13357
(3000963) Hemoglobin [Mass/volume] in Blood
1445
13731
1.82
7.70
21.4
21.7
g/l
141.6
140.6
1.52
1434
13538
(3010813) Leukocytes [#/volume] in Blood
1445
13733
1.81
7.67
21.4
21.6
e9/l
6.8
6.8
0.02
1419
13359
(3035941) MCH [Entitic mass]
1444
13726
1.80
7.58
21.2
21.5
pg
30.5
30.5
0.19
1435
13541
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
72
1343
0.51
7.23
3.4
3.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1441
13715
1.76
7.17
21.4
21.6
e9/l
232.6
236.6
1.60
1418
13389
(3014576) Chloride [Moles/volume] in Serum or Plasma
111
1817
0.58
7.09
7.7
7.9
mmol/l
105.4
104.4
1.64
101
1775
(40761536) Microorganisms panel - Urine sediment
46
996
0.45
7.09
3.7
3.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1358
12751
1.54
7.00
15.9
14.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
906
7992
1.32
6.61
4.8
3.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
913
8074
1.32
6.48
3.2
3.2
pmol/l
14.8
14.8
0.37
823
7319
(3014007) Fractional oxyhemoglobin in Arterial blood
44
932
0.46
6.41
13.1
10.9
%
94.7
94.0
0.68
44
927
(4010399)
133
839
1.64
6.40
1.4
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1303
12181
1.45
6.38
14.7
15.1
mg/l
25.2
27.0
1.00
1048
9695
(36304419) Bacteria [Presence] in Urine
254
3398
0.70
6.32
3.1
3.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1236
11454
1.40
6.30
5.7
5.9
mmol/mol
39.7
40.4
2.31
1162
10701
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
36
143
2.55
6.30
2.5
2.4
mg/l
29.9
20.5
0.43
15
36
(3000991) Gas panel - Venous blood
64
1184
0.52
6.26
11.2
10.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
131
832
1.63
6.15
3.7
3.7
mmol/l
2.1
1.8
0.58
88
617
(4024509)
26
88
2.99
6.12
1.5
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
161
1085
1.54
5.88
2.8
2.8
ng/l
191.9
212.9
0.26
144
985
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
838
7380
1.30
5.86
2.9
2.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1338
12616
1.45
5.82
17.3
17.6
mmol/l
139.9
139.7
2.80
1312
12333
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
14
32
4.41
5.77
1.6
1.1
%
18.6
36.0
1.21
14
25
(3023103) Potassium [Moles/volume] in Serum or Plasma
1342
12666
1.46
5.75
17.4
17.8
mmol/l
4.0
4.0
0.43
1313
12367
(3013512) EKG study
434
3507
1.33
5.71
4.6
4.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
47
932
0.49
5.70
12.3
10.7
%
1.6
1.4
0.84
47
926
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
127
817
1.60
5.67
9.6
12.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
47
928
0.49
5.63
12.4
10.8
%
0.6
0.7
0.34
47
919
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
135
883
1.58
5.62
3.7
3.7
kpa
5.1
5.2
0.08
128
813
(3022313) Gas panel - Capillary blood
102
622
1.69
5.62
4.0
3.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1128
10372
1.32
5.55
4.0
3.9
mu/l
1.9
2.1
0.66
1019
9440
(3013707) Erythrocyte sedimentation rate by Westergren method
960
8642
1.29
5.51
4.4
3.9
mm/h
9.5
11.3
4.35
908
8031
(3009542) Hematocrit [Volume Fraction] of Blood
1210
11249
1.35
5.46
15.4
15.8
%
40.9
41.2
0.39
825
8188
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
575
4855
1.29
5.43
3.9
3.7
ng/l
44.1
61.2
0.79
405
3537
(3009343) pH of Capillary blood
132
871
1.56
5.30
3.7
3.8
ph
7.4
7.4
—
10
110
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
94
570
1.69
5.30
2.6
2.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
90
540
1.71
5.27
2.0
2.0
—
—
—
0
0
(4133840)
15
40
3.78
5.09
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
947
8567
1.27
4.94
3.5
3.3
u/l
52.1
57.4
1.25
906
8044
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
72
1193
0.58
4.81
2.6
2.6
u/l
35.7
79.9
0.58
60
1049
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
82
493
1.70
4.79
1.9
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
825
7358
1.26
4.78
4.3
4.0
e6/l
3.4
1225.4
—
7
119
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
53
936
0.55
4.48
3.8
4.5
mmol/l
1.2
1.2
0.22
47
835
(40758558) Short blood count panel - Blood
228
2949
0.73
4.44
5.8
7.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
159
2178
0.70
4.39
2.9
3.0
e6/l
0.8
0.9
0.18
110
1308
(3045414) Leukocytes [Presence] in Urine
79
483
1.67
4.37
2.1
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
31
139
2.26
4.26
1.2
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
31
139
2.26
4.26
1.2
1.6
—
—
—
0
0
(3020891) Body temperature
27
584
0.45
4.23
4.3
4.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
357
4300
0.78
4.09
4.0
3.8
e6/l
70.6
110.5
0.50
282
3232
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1015
9357
1.25
4.05
7.2
8.0
u/l
75.7
78.2
0.92
964
8899
(3008152) Bicarbonate [Moles/volume] in Arterial blood
133
933
1.47
4.05
6.6
7.7
mmol/l
24.7
24.4
0.34
122
869
(3005988) Vibrio sp identified in Specimen by Organism specific culture
30
137
2.21
3.97
1.2
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
30
137
2.21
3.97
1.2
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
26
112
2.34
3.93
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
171
1277
1.38
3.69
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
738
6620
1.22
3.66
4.6
4.1
%
21.4
21.6
0.16
331
3096
(3025468) Yersinia sp identified in Specimen by Organism specific culture
29
136
2.15
3.62
1.2
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
29
136
2.15
3.62
1.2
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
213
1655
1.33
3.57
1.3
1.2
iu/ml
56.1
32.9
0.64
66
501
(3002582) Erythrocytes [#/volume] in Urine
323
3851
0.80
3.28
3.4
3.4
e6/l
27.1
93.3
3.10
275
3046
(36660697) Celiac disease serology panel - Serum
108
761
1.45
3.26
1.2
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
50
815
0.60
3.20
10.5
9.3
mmol/l
23.8
24.6
0.73
50
810
(3027315) Oxygen [Partial pressure] in Blood
12
320
0.37
3.19
4.8
5.6
kpa
8.2
8.6
0.47
12
315
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
481
4182
1.22
3.15
3.8
3.5
u/l
33.2
40.3
1.05
449
3964
(3012501) Base excess in Blood by calculation
12
318
0.37
3.15
4.8
5.5
mmol/l
1.6
2.4
—
7
214
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
74
2.45
3.05
1.1
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
57
2.65
2.97
12.0
14.9
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
26
128
2.05
2.92
1.3
1.3
e6/l
48608.0
47502.0
0.01
14
94
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
642
5769
1.19
2.91
7.4
7.9
mmol/l
1.2
1.2
3.60
558
4905
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
46
274
1.70
2.89
1.1
1.1
u/ml
6.8
2.5
—
5
29
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
537
4763
1.20
2.79
1.9
2.0
pmol/l
97.8
92.5
1.68
297
2745
(4035726)
69
1008
0.67
2.73
1.3
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
42
251
1.69
2.64
1.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
26
134
1.96
2.61
1.2
1.2
mmol/l
6.5
7.5
1.00
17
108
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
73
500
1.48
2.59
3.4
2.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
222
2693
0.79
2.58
4.0
4.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
74
2.31
2.58
1.1
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
502
4452
1.19
2.57
3.6
3.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
90
1237
0.71
2.56
8.0
8.4
mmol/l
1.4
1.4
0.06
84
1194
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
193
1550
1.28
2.56
1.3
1.2
u/ml
12.3
9.7
0.18
66
623
(3019060) Gas panel - Arterial blood
129
985
1.34
2.48
5.7
5.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
94
1274
0.72
2.47
3.7
4.1
kpa
5.9
5.8
0.03
89
1236
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
50
762
0.64
2.45
11.6
11.6
mmol/l
23.5
24.2
0.69
44
716
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
63
0.00
2.43
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
34
2.95
2.41
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
620
5621
1.17
2.41
4.8
4.4
estimate
0.0
0.0
0.00
58
1095
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
162
0.31
2.40
1.4
2.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
221
2660
0.80
2.39
2.6
2.7
e6/l
2.9
3.2
0.48
197
2364
(3012095) Magnesium [Moles/volume] in Serum or Plasma
173
2141
0.78
2.38
3.0
3.8
mmol/l
0.8
0.8
0.98
162
2035
(3045424) Erythrocytes [Presence] in Urine
36
213
1.71
2.37
1.3
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
584
5275
1.17
2.37
6.1
7.1
mmol/l
1.2
1.2
1.52
515
4821
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
165
2049
0.78
2.34
3.3
3.2
e6/l
1.0
0.7
0.69
114
1183
(3009261) Glucose [Presence] in Urine by Test strip
627
5701
1.17
2.33
3.4
3.3
estimate
0.0
0.0
0.50
53
1014
(3035350) Ketones [Presence] in Urine by Test strip
623
5662
1.17
2.33
3.4
3.3
estimate
0.0
0.0
0.49
52
1053
(3048689) Calprotectin [Mass/mass] in Stool
157
1246
1.29
2.30
2.2
2.6
ug/g
109.5
170.9
1.99
126
1019
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
315
0.47
2.30
1.4
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
310
2666
1.20
2.21
3.5
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
96
1268
0.74
2.16
3.6
4.1
mmol/l
1.8
1.8
0.03
70
1015
(3018418) pH of Serum or Plasma
288
3337
0.83
2.13
3.8
4.8
ph
7.4
7.4
0.34
27
667
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
290
2487
1.20
2.12
4.5
3.8
ng/l
683.2
585.7
0.10
223
2020
(3019309) Folate [Moles/volume] in Red Blood Cells
254
2152
1.22
2.11
1.6
1.8
nmol/l
892.4
1141.1
6.23
205
1688
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
422
3744
1.17
2.10
2.0
2.3
u/l
221.6
303.5
0.83
394
3528
(3041096) Erythrocytes [Presence] in Urine by Automated
357
3126
1.18
2.08
3.2
3.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
55
0.00
2.07
0.0
1.4
—
89.9
—
0
55
(3032080) INR in Blood by Coagulation assay
582
5301
1.16
2.05
9.7
10.3
inr
1.3
1.3
0.25
152
1506
(3052592) Norovirus Ag [Presence] in Stool
7
20
3.51
2.05
1.7
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
101
768
1.34
2.04
2.7
2.3
au/ml
23.3
22.1
—
6
35
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
43
646
0.66
2.02
3.3
2.8
%
0.7
0.7
0.27
43
619
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
26
3.09
2.01
1.5
1.8
mmol/l
1.2
1.2
—
8
26
(3014051) Protein [Presence] in Urine by Test strip
36
224
1.62
2.00
2.9
2.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
463
4155
1.16
1.98
5.3
6.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
257
0.46
1.97
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
257
0.46
1.97
1.3
1.3
—
—
—
0
0
(4146454)
25
141
1.79
1.97
2.8
2.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
75
551
1.38
1.90
4.0
3.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
144
1.75
1.85
1.7
1.5
%
74.3
60.7
1.19
20
100
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
64
460
1.41
1.84
1.1
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
328
0.54
1.84
4.4
4.3
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
5
12
4.18
1.82
1.0
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
211
2479
0.83
1.80
3.3
2.9
mosm/kgh2o
628.4
586.2
1.65
168
2139
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
198
1664
1.22
1.80
1.5
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
414
4596
0.86
1.78
3.2
3.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
685
6366
1.14
1.73
6.0
6.9
umol/l
12.0
12.6
0.87
651
6086
(3038177) Helicobacter pylori Ab [Presence] in Serum
29
178
1.64
1.73
1.2
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
505
0.65
1.72
2.4
2.9
u/ml
0.4
0.3
0.36
22
282
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
148
1212
1.24
1.72
1.6
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
439
4842
0.87
1.72
3.0
2.9
ug/l
0.7
0.7
0.53
266
3128
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
320
0.56
1.71
1.4
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
213
0.47
1.66
2.0
3.1
u/ml
3.0
126.8
—
10
204
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
49
2.25
1.63
5.3
7.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
614
5686
1.13
1.62
5.4
6.3
%
57.2
57.7
0.50
577
5370
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
14
3.58
1.61
1.2
1.2
umol/24h
2.1
2.1
—
5
14
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
237
0.50
1.61
1.2
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
26
160
1.64
1.56
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
20
335
0.59
1.55
2.0
2.7
g/l
0.1
0.0
0.48
20
310
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
28
430
0.64
1.52
1.4
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
144
0.41
1.51
1.3
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
20
332
0.60
1.51
2.0
2.7
g/l
0.0
0.0
0.00
20
310
(3027945) Reticulocytes/100 erythrocytes in Blood
122
1485
0.81
1.50
2.0
2.5
%
1.9
1.7
0.45
111
1330
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
18
101
1.79
1.49
1.3
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
330
0.60
1.48
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
202
0.49
1.46
1.3
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
38
2.38
1.45
1.1
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
11
52
2.12
1.44
2.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
59
2.04
1.43
1.2
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
59
2.04
1.43
1.2
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
122
1001
1.24
1.43
1.4
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
19
110
1.74
1.43
1.9
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
620
5779
1.12
1.43
5.5
6.5
%
27.7
26.9
1.02
576
5436
(3037522) Nuclear Ab [Titer] in Serum
171
1453
1.20
1.42
1.3
1.3
titre
620.0
366.1
0.86
22
282
(21494755) Public health laboratory ask at order entry panel
156
1316
1.21
1.40
1.4
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
150
1.61
1.38
3.3
4.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
95
763
1.26
1.35
1.3
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
61
462
1.33
1.34
2.4
3.4
g/l
0.4
0.3
0.40
21
229
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
235
2063
1.16
1.34
2.0
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
128
1.65
1.33
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
48
352
1.38
1.30
1.1
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
21
129
1.64
1.30
1.5
2.5
e9/l
1.0
1.1
—
10
70
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
262
2941
0.87
1.30
2.7
2.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
34
2.36
1.29
2.3
2.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.6
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
57
431
1.33
1.28
1.9
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
601
5620
1.11
1.28
4.9
4.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
215
1882
1.17
1.28
2.0
2.3
nmol/l
13.5
13.8
0.17
191
1686
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
35
2.29
1.27
5.8
8.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
44
2.05
1.27
5.2
7.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
158
1350
1.19
1.26
1.3
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
12
216
0.55
1.25
3.0
2.1
mmol/l
1.6
1.7
0.05
12
208
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
21
133
1.59
1.17
1.2
1.4
nmol/l
0.6
0.6
0.30
21
127
(3024928) Oxygen saturation in Venous blood
20
308
0.64
1.15
5.0
3.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
39
2.06
1.15
2.4
2.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
103
1234
0.82
1.13
1.7
2.4
ug/l
6.8
8.8
0.78
83
1132
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
112
0.44
1.13
1.4
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
129
1508
0.84
1.09
1.3
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
273
2460
1.13
1.09
1.7
1.7
pmol/l
152542775.5
36716545.4
0.84
236
2089
(3012516) Albumin [Mass/volume] in Urine
424
3921
1.11
1.09
3.3
3.4
mg/l
593.7
247.8
0.66
280
2740
(3026493) Urate [Moles/volume] in Serum or Plasma
384
3532
1.12
1.09
2.4
2.9
umol/l
1157.4
4945.1
3.20
352
3132
(4015189)
8
41
1.96
1.09
1.9
2.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
68
542
1.27
1.08
1.9
1.8
u/l
33.8
38.8
1.37
62
481
(3020191) Ethanol [Moles/volume] in Serum or Plasma
20
129
1.56
1.05
1.2
1.5
promille
1.2
1.3
0.07
14
100
(3006184) Hemoglobin [Mass/volume] in Capillary blood
39
288
1.36
1.05
2.5
2.4
g/l
137.2
131.3
0.85
28
207
(40761535) Cells panel - Urine sediment
87
1050
0.82
1.04
2.3
3.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
125
0.48
1.04
3.8
2.1
ml
831.5
655.6
—
6
72
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
25
358
0.69
1.03
2.0
2.7
g/l
0.2
0.0
0.88
25
333
(3009508) Creatinine [Moles/volume] in Urine
449
4185
1.10
0.99
3.1
3.4
mmol/l
9.0
8.7
0.78
377
3538
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
29
0.00
0.97
0.0
2.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
18
116
1.56
0.96
1.2
1.4
nmol/l
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
9
50
1.80
0.96
1.1
1.6
mmol/l
2.6
3.5
—
9
44
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
50
1.80
0.96
1.4
3.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
247
0.64
0.96
3.0
3.8
%
55.4
57.3
0.25
16
247
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
352
3245
1.11
0.96
1.8
1.7
mmol/l
1.4
1.5
0.27
306
2710
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
394
3656
1.10
0.95
3.0
3.1
ng/l
1130.2
1557.2
1.56
326
3163
(3002173) Hemoglobin [Mass/volume] in Arterial blood
160
1406
1.15
0.94
8.3
9.6
g/l
127.2
124.6
0.78
147
1348
(3020491) Glucose [Moles/volume] in Blood
14
85
1.65
0.94
2.4
2.5
mmol/l
7.9
7.3
—
8
57
(3044007) Cell count panel - Peritoneal fluid
7
37
1.90
0.94
2.4
2.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
27
374
0.72
0.94
1.9
2.6
g/l
38.1
37.6
0.12
22
327
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
295
1.33
0.93
1.4
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
384
0.72
0.92
2.7
2.3
ug/min
167.1
108.2
0.18
20
233
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
244
0.65
0.92
1.7
2.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
15
94
1.60
0.90
1.4
2.3
%
14.4
13.6
—
10
38
(3006504) Eosinophils/100 leukocytes in Blood
593
5621
1.09
0.90
5.6
6.4
%
2.9
2.9
0.07
559
5292
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
160
1.44
0.89
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
89
1051
0.84
0.88
2.1
2.7
ml/min/173m2
62.3
66.2
0.36
39
395
(3036782) Glucose [Moles/volume] in Pleural fluid
9
156
0.57
0.88
1.2
1.5
mmol/l
6.7
6.4
—
9
147
(3019069) Monocytes/100 leukocytes in Blood
595
5646
1.09
0.88
6.0
6.7
%
8.8
9.1
0.90
563
5332
(3013826) Glucose [Moles/volume] in Serum or Plasma
775
7437
1.08
0.87
5.1
5.5
mmol/l
6.8
6.9
0.47
732
7018
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
239
0.67
0.85
2.9
3.5
e9/l
3.6
4.3
0.85
16
239
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
138
1567
0.87
0.85
1.5
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
297
0.70
0.84
1.8
1.4
—
—
—
0
0
(3036489) Thrombin time
36
466
0.77
0.82
1.7
2.1
s
24.9
21.9
0.39
31
414
(3015183) Erythrocyte sedimentation rate
11
65
1.70
0.82
1.4
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
47
1.71
0.80
1.3
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
47
1.71
0.80
1.7
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
131
1486
0.87
0.80
1.7
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
43
339
1.28
0.79
2.6
2.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
33
1.82
0.79
1.5
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
81
953
0.84
0.79
1.4
1.6
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
25
0.00
0.79
0.0
3.8
—
3786.4
—
0
25
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
50
617
0.80
0.79
4.3
4.0
%
50.5
49.6
0.10
50
609
(3023520) Reticulocytes [#/volume] in Blood
97
1122
0.86
0.77
2.1
2.6
e9/l
69.8
69.6
0.02
87
866
(3013139) Helicobacter pylori Ag [Presence] in Stool
78
659
1.19
0.77
1.3
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
40
314
1.28
0.77
2.3
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
34
1.77
0.76
1.2
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
59
1.70
0.76
4.0
2.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
166
1845
0.89
0.75
2.5
2.8
g/l
2.3
2.3
0.52
154
1731
(3044941) Cell count panel - Synovial fluid
27
201
1.35
0.74
1.4
1.4
—
—
—
0
0
(4034850)
31
402
0.77
0.74
9.2
10.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
39
307
1.28
0.74
4.4
4.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
27
357
0.75
0.74
2.6
3.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
33
423
0.78
0.72
1.5
1.7
mg/l
2.7
4.7
0.96
21
297
(3016502) Oxygen saturation in Arterial blood
170
1532
1.12
0.72
7.9
9.0
%
96.5
95.6
1.44
160
1474
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
56
1.61
0.72
2.1
2.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
56
1.61
0.72
2.1
2.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
110
0.54
0.72
1.2
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
271
2506
1.10
0.71
1.6
1.7
mg/l
1.0
1.4
2.93
211
1915
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
57
1.58
0.71
2.1
2.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
327
1.26
0.71
1.6
1.5
ug/g
285.0
260.0
0.39
23
205
(3020682) Albumin/Creatinine [Ratio] in Urine
437
4129
1.08
0.70
3.8
4.2
mg/mmol
5.8
10.1
2.51
297
2853
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
126
1.43
0.70
2.1
2.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
120
1354
0.88
0.70
6.8
8.4
mmol/l
10.1
10.4
0.19
115
1299
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
58
1.55
0.69
1.7
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
42
1.67
0.68
1.3
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
120
0.58
0.67
1.6
2.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
44
358
1.24
0.65
1.2
1.1
—
0.8
—
0
5
(3013115) Eosinophils [#/volume] in Blood
649
6238
1.07
0.65
4.9
6.4
e9/l
0.2
0.2
0.06
586
5499
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
38
304
1.26
0.65
1.5
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
292
2723
1.09
0.65
1.6
1.6
nmol/l
18.6
19.2
0.28
247
2354
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
108
1220
0.88
0.65
2.1
2.3
g/l
0.2
0.2
2.00
103
1132
(40768804) Tissue Pathology biopsy report
462
4390
1.07
0.64
2.1
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
326
0.76
0.64
1.5
4.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
105
927
1.14
0.63
2.3
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
32
403
0.79
0.63
1.6
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
87
1.50
0.63
1.5
2.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
572
5480
1.07
0.63
5.3
6.5
%
0.6
0.7
0.46
536
5167
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
272
2916
0.92
0.63
2.1
2.1
mg/l
2.9
2.9
0.04
244
2491
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
34
270
1.27
0.62
1.3
1.2
—
388.9
—
0
9
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
79
1.52
0.62
1.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
71
1.55
0.62
1.1
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
70
601
1.17
0.61
1.8
2.0
ug/l
2.1
2.0
0.02
59
544
(3044640) Blood type and Crossmatch panel - Blood
360
3812
0.93
0.61
3.2
2.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
33
262
1.27
0.61
2.0
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
70
602
1.17
0.60
1.2
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
140
0.64
0.60
2.8
4.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
51
1.57
0.60
1.3
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
80
1.50
0.60
1.0
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1029
10063
1.07
0.59
17.2
18.1
%
13.7
13.7
0.12
1011
9847
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
88
773
1.15
0.58
4.1
5.1
ng/l
101.1
104.8
0.10
79
689
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
140
1.36
0.58
1.1
1.1
u/ml
0.3
3.0
—
8
55
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
23
0.00
0.58
0.0
6.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
7
115
0.61
0.58
1.1
1.3
—
185.7
—
0
23
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
115
0.61
0.58
1.0
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
439
4182
1.07
0.57
2.0
2.2
nmol/l
73.1
74.5
0.52
397
3766
(1002224) Polysomnography panel
49
581
0.84
0.56
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
38
311
1.23
0.56
2.5
1.7
nmol/l
0.8
0.8
0.09
33
273
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
89
0.56
0.56
1.0
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
5
90
0.55
0.55
4.2
2.2
min
502.2
488.5
—
5
60
(3044290) Cell count panel - Cerebral spinal fluid
30
239
1.26
0.55
1.4
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
133
1465
0.90
0.55
2.6
3.1
umol/l
7.5
9.3
0.84
123
1314
(3003396) Base excess in Arterial blood by calculation
181
1667
1.10
0.55
7.7
8.6
mmol/l
1.2
0.9
0.47
135
1297
(3017704) Immunofixation for Urine
12
82
1.47
0.54
1.5
1.5
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
6
38
1.58
0.54
1.0
1.3
nmol/l
472.5
148.1
—
6
25
(46235355) HIV 1 and 2 tests - Meaningful Use set
182
1970
0.91
0.53
1.9
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
43
512
0.84
0.53
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
348
3668
0.93
0.53
2.9
3.5
mmol/l
2.3
2.3
1.06
297
3227
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
45
378
1.20
0.52
1.8
1.7
—
—
—
0
0
(4306422)
14
192
0.73
0.52
1.0
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
270
0.77
0.51
1.2
1.2
u/ml
288.3
297.9
0.06
13
172
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
161
1748
0.91
0.51
2.6
2.8
%
23.5
23.9
0.11
110
1514
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
75
1.47
0.50
1.2
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
65
1.39
0.50
1.3
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
41
1.47
0.50
1.3
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
42
353
1.20
0.49
1.2
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
45
1.56
0.49
1.0
1.0
miu/ml
1351.3
1304.6
—
7
45
(3027801) Oxygen [Partial pressure] in Arterial blood
180
1669
1.09
0.48
7.8
8.6
kpa
12.1
12.1
0.01
167
1599
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
180
1669
1.09
0.48
7.7
8.6
kpa
5.0
5.1
1.24
166
1596
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
32
388
0.82
0.48
2.9
3.0
mg/l
1.6
1.6
0.18
27
351
(3049717) Cytology report of Urine Cyto stain
73
644
1.14
0.48
3.3
2.8
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
11
76
1.45
0.48
1.0
1.1
mmol/l
34.3
35.3
0.08
11
67
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
17
128
1.33
0.47
1.2
1.4
pmol/l
310.7
264.5
0.21
12
105
(3008898) HLA-B27 [Presence]
41
346
1.19
0.47
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
68
1.47
0.47
1.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
21
164
1.28
0.46
1.6
2.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
112
1018
1.11
0.46
2.4
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
81
0.62
0.46
2.0
2.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
81
0.62
0.46
1.4
3.8
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
17
129
1.32
0.45
1.1
1.1
u/ml
1.5
3.1
—
9
53
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
30
246
1.22
0.45
1.3
1.2
u/ml
1.6
5.0
—
5
18
(40768806) Pleura Pathology biopsy report
20
156
1.29
0.45
1.5
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
33
395
0.83
0.45
1.5
1.4
u/l
5.4
5.9
0.27
28
319
(3022217) INR in Platelet poor plasma by Coagulation assay
183
1706
1.08
0.44
19.7
25.6
inr
1.7
1.3
1.33
30
249
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
56
640
0.87
0.44
1.4
1.8
g/l
1.4
1.6
0.40
51
552
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
43
501
0.85
0.44
1.9
2.4
ug/l
237.5
696.1
2.02
43
479
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
285
0.80
0.43
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
196
0.76
0.43
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
17
218
0.78
0.42
1.5
4.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
50
434
1.16
0.42
1.4
3.3
—
—
—
0
0
(3015736) pH of Urine
458
4411
1.05
0.42
3.2
3.1
—
5.8
—
0
6
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
32
1.56
0.42
1.0
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
6
95
0.63
0.42
1.2
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
140
1512
0.92
0.42
1.8
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
70
1.43
0.41
1.3
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
206
0.77
0.41
1.1
1.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.8
—
206.1
—
0
15
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
16
0.00
0.41
0.0
2.7
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
(3025315) Body weight
0
16
0.00
0.41
0.0
2.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
222
1.22
0.41
1.5
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
62
549
1.13
0.41
1.5
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
90
991
0.90
0.40
2.3
2.8
g/l
10.3
10.7
0.44
81
914
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
270
0.81
0.39
1.2
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
196
1.23
0.39
1.2
1.1
u/ml
1.2
1.9
0.28
12
82
(4268621)
10
137
0.73
0.39
2.0
2.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
26
313
0.83
0.39
1.5
1.6
mu/l
203.8
264.1
1.79
26
291
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
124
1.29
0.38
1.3
1.4
—
—
—
0
0
(4062490)
16
124
1.29
0.38
1.2
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
16
124
1.29
0.38
1.2
1.3
g/l
5.4
7.0
—
10
85
(3024139) IgG subclass 3 [Mass/volume] in Serum
16
124
1.29
0.38
1.2
1.3
g/l
0.4
0.4
0.37
11
84
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
124
1.29
0.38
1.2
1.3
g/l
2.4
3.1
0.94
11
86
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
32
270
1.19
0.38
2.9
2.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
78
704
1.11
0.38
1.7
1.7
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
9
66
1.37
0.38
1.0
1.4
—
258.6
—
0
7
(3036048) Francisella tularensis Ab [Titer] in Serum
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
36
1.39
0.38
1.4
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
112
0.71
0.37
1.4
3.9
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
42
482
0.87
0.37
2.6
4.0
u/ml
141.2
4368.5
0.99
35
404
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
114
0.70
0.37
1.1
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
37
1.35
0.37
1.4
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
93
850
1.10
0.37
1.5
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
17
134
1.27
0.37
1.2
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
2.1
2.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
2.1
2.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
2.1
2.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
2.1
2.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
81
1.36
0.36
1.1
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
77
0.65
0.35
1.6
2.9
ml
2030.0
1981.5
—
5
69
(3009871) Measles virus Ab [Titer] in Serum
6
42
1.43
0.35
1.7
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
99
1.32
0.35
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
124
0.72
0.35
1.7
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
199
1.21
0.35
1.3
1.5
pmol/l
64.9
202.2
0.46
12
64
(3006315) Basophils [#/volume] in Blood
619
6033
1.04
0.35
4.9
6.1
e9/l
0.0
0.0
0.39
563
5240
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
156
0.77
0.34
1.2
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
633
6176
1.04
0.34
4.8
6.2
e9/l
1.9
2.0
0.13
576
5445
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
118
1.27
0.33
1.4
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
166
0.78
0.33
1.3
1.5
e6/l
24197.5
62468.2
—
8
107
(3001604) Monocytes [#/volume] in Blood
616
6011
1.04
0.32
4.9
6.1
e9/l
0.6
0.6
0.74
560
5215
(3036071) Salmonella sp Ab [Titer] in Serum
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
166
1568
1.07
0.31
1.2
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
53
1.32
0.31
1.4
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
53
1.32
0.31
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
18
147
1.23
0.30
1.2
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
129
1.24
0.30
1.8
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
120
1.25
0.30
1.1
1.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
55
1.27
0.30
1.4
2.7
—
34310.1
—
0
14
(3028026) IgM [Mass/volume] in Serum or Plasma
71
775
0.91
0.30
1.4
2.0
g/l
1.0
1.4
0.98
63
717
(40760888) Immunoglobulin light chains.free panel - Serum
27
313
0.86
0.29
2.1
3.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
57
1.23
0.29
1.0
5.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
29
334
0.87
0.29
1.4
1.3
g/l
1.3
1.2
1.11
29
321
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
184
0.81
0.28
2.5
4.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
94
1.28
0.28
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
62
1.29
0.28
1.0
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
30
261
1.15
0.27
3.0
3.6
mmol/l
6.7
7.6
1.81
30
255
(3011648) Oxygen content in Venous blood
9
119
0.75
0.27
3.6
2.0
%
10.2
11.7
—
9
119
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
65
1.23
0.27
1.4
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
71
0.70
0.26
1.8
3.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
28
320
0.87
0.26
1.5
1.3
g/l
0.2
0.2
0.11
28
306
(3047189) Immunofixation for 24 hour Urine
5
75
0.67
0.26
1.4
1.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
149
0.80
0.25
1.3
2.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
72
1.25
0.25
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
51
464
1.10
0.25
1.4
3.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
17
142
1.20
0.24
1.1
1.4
—
—
—
0
0
(44790047)
19
161
1.18
0.24
1.2
1.7
—
—
—
0
0
(44790048)
19
161
1.18
0.24
1.2
1.7
—
—
—
0
0
(44790049)
19
161
1.18
0.24
1.2
1.7
—
—
—
0
0
(44806118)
19
161
1.18
0.24
1.2
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
212
0.85
0.24
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
212
0.85
0.24
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
127
1203
1.06
0.24
1.5
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
18
152
1.19
0.23
1.1
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
439
4498
0.97
0.23
2.5
2.8
ug/l
162.2
183.0
1.18
413
4172
(1001926) Buprenorphine [Presence] in Urine by Screen method
41
370
1.11
0.23
1.4
3.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
17
143
1.19
0.23
1.2
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
891
8795
1.03
0.23
3.8
3.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
163
1558
1.05
0.23
3.8
4.2
u/l
257.5
240.0
0.71
157
1486
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
157
1500
1.05
0.22
5.0
7.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
41
1.22
0.22
2.2
2.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
41
1.22
0.22
1.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
51
468
1.09
0.22
1.4
3.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
51
468
1.09
0.22
1.4
2.7
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
11
0.00
0.21
0.0
4.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
10
0.00
0.21
0.0
5.1
—
391.9
—
0
10
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001729) Color of Synovial fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
220
1.14
0.21
3.0
2.8
nmol/l
0.7
0.8
1.04
25
167
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
17.3
—
0
13
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
13
(3042517) Benzodiazepines panel - Urine
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
30
268
1.12
0.20
1.4
1.2
mmol/l
3.5
3.9
1.49
25
249
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
145
1.17
0.20
1.8
2.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
117
1.20
0.20
1.6
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
23
261
0.88
0.20
1.5
1.7
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
72
768
0.93
0.20
1.8
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
254
2618
0.96
0.19
3.4
3.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
19
218
0.87
0.19
1.5
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
43
395
1.09
0.19
1.6
1.6
iu/ml
35.1
1.9
0.50
11
85
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
225
2180
1.04
0.18
1.3
1.2
u/ml
2.0
1.5
0.42
48
599
(3023511) Choriogonadotropin [Units/volume] in Urine
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
156
1.16
0.18
1.8
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
166
1.15
0.18
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
94
989
0.95
0.18
4.1
4.6
%
0.1
0.1
0.07
32
308
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
60
1.17
0.17
1.3
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
61
1.15
0.17
2.0
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
46
496
0.93
0.17
1.4
1.2
iu/ml
87.1
136.5
0.71
19
164
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
157
1.15
0.17
1.2
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
24
268
0.89
0.17
1.4
1.5
u/ml
126.0
122.6
—
7
52
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
127
1218
1.05
0.17
3.3
4.6
ug/l
7.1
24.1
1.52
93
1024
(3042733) HLA Ab [Presence] in Serum
5
67
0.75
0.17
6.2
5.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
215
1.12
0.16
1.1
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
18
158
1.14
0.16
3.6
5.7
mmol/l
7.0
7.4
0.34
13
133
(3004716) Salmonella sp identified in Stool by Organism specific culture
50
467
1.07
0.16
1.4
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
78
0.77
0.15
1.2
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
35
322
1.09
0.15
1.4
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
80
841
0.95
0.15
2.1
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
79
0.76
0.15
1.2
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
81
851
0.95
0.15
3.9
3.4
g/l
133.2
130.1
0.55
74
830
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
9
80
1.13
0.15
1.3
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
49
459
1.07
0.14
1.4
3.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
150
0.87
0.14
2.3
2.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
100
1042
0.96
0.14
2.5
2.2
nmol/l
440.5
363.4
1.30
93
970
(3003694) ABO and Rh group [Type] in Blood
333
3395
0.98
0.14
1.3
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
316
3097
1.03
0.14
3.4
3.6
estimate
0.0
0.0
0.69
54
1003
(3013650) Neutrophils [#/volume] in Blood by Automated count
682
6894
0.98
0.13
7.5
9.7
e9/l
4.1
4.3
0.51
613
6038
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
190
1950
0.97
0.13
1.8
2.0
%
1.4
1.6
2.31
168
1719
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
209
1.10
0.13
1.5
1.9
iu/l
6.2
6.0
—
10
72
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
108
0.83
0.13
1.4
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
25
272
0.92
0.12
1.5
1.3
e6/l
214.1
1495.3
1.03
19
218
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
25
272
0.92
0.12
1.4
1.3
e6/l
36.5
39.6
0.04
19
210
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
191
1.10
0.11
1.1
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
147
0.88
0.11
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
269
1.08
0.11
1.2
1.3
miu/ml
112.3
198.6
—
9
111
(3023183) Ammonium ion [Moles/volume] in Plasma
33
353
0.93
0.11
2.5
2.9
umol/l
30.6
37.7
1.22
28
297
(3020630) Protein [Mass/volume] in Serum or Plasma
101
1044
0.97
0.11
2.0
2.8
g/l
65.8
66.4
0.28
91
971
(3008037) Lactate [Moles/volume] in Venous blood
30
280
1.07
0.10
3.0
3.5
mmol/l
1.5
1.6
0.56
30
273
(3000093) Morphology [Interpretation] in Blood Narrative
11
125
0.88
0.10
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
310
0.93
0.10
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
48
1.04
0.09
1.0
1.5
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.1
—
0.5
—
0
9
(3018677) aPTT in Platelet poor plasma by Coagulation assay
211
2072
1.02
0.09
1.7
2.2
s
29.4
30.1
1.08
198
2019
(3042631) Mycobacterium sp identified in Specimen
21
194
1.08
0.09
2.1
2.9
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
6
54
1.11
0.09
1.8
1.4
%
—
3.1
—
0
12
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
56
1.07
0.08
2.0
2.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
136
1.10
0.08
1.2
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
194
1975
0.98
0.08
2.3
2.8
umol/l
12.7
13.4
0.69
182
1856
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
61
0.82
0.08
1.2
1.2
iu/ml
143.6
179.2
—
5
61
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
440
0.95
0.08
1.7
2.7
g/l
2.7
3.0
1.24
26
356
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
66
1.06
0.08
2.7
4.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
244
1.07
0.08
1.1
1.6
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
6
71
0.84
0.07
1.0
1.2
—
3.4
—
0
5
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
70
0.86
0.07
2.0
1.7
—
—
—
0
0
(4027681)
6
72
0.83
0.07
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
193
1898
1.02
0.07
2.0
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
37
388
0.95
0.07
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
235
0.94
0.07
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
306
0.95
0.07
1.2
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
53
511
1.04
0.07
3.1
3.7
pmol/l
4.5
4.5
0.04
48
465
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
86
1.05
0.07
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
377
3733
1.01
0.07
4.2
4.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
89
1.12
0.07
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
89
1.12
0.07
1.0
1.0
—
—
—
0
0
(4094501)
40
384
1.04
0.06
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
28
266
1.05
0.06
3.6
3.4
mg/l
41.3
29.2
0.71
14
167
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
144
1416
1.02
0.06
1.9
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
233
0.94
0.06
1.1
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
107
1049
1.02
0.05
4.3
4.5
%
0.4
0.8
1.99
34
336
(3002179) Metamyelocytes/100 leukocytes in Blood
97
950
1.02
0.05
4.4
4.2
%
0.6
0.5
0.08
29
247
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
129
1.09
0.05
1.1
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1161
11641
0.99
0.05
12.9
13.9
ml/min/173m2
80.4
82.0
1.72
924
9680
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
34
326
1.04
0.05
1.5
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
222
0.95
0.05
1.2
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
120
0.92
0.05
1.2
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
443
0.97
0.04
1.8
2.7
g/l
11.0
10.6
0.20
31
383
(3009445) Proteinase 3 Ab [Units/volume] in Serum
60
586
1.02
0.04
1.2
1.5
—
23.8
—
0
21
(40768443) Skin Pathology biopsy report
49
503
0.97
0.04
1.1
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
111
1.08
0.04
1.2
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
200
0.95
0.03
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
468
4702
0.99
0.03
2.5
2.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
171
1.05
0.03
1.1
1.1
u/ml
0.6
1.0
—
8
65
(3007164) IgA [Mass/volume] in Serum or Plasma
206
2076
0.99
0.03
1.4
1.5
g/l
2.5
2.7
0.82
126
1354
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
78
768
1.02
0.03
1.8
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
92
931
0.99
0.02
4.5
4.6
%
0.1
0.1
0.23
28
263
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
471
1.02
0.02
1.9
2.6
g/l
7.0
7.1
0.13
27
361
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
471
1.02
0.02
1.9
2.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
471
1.02
0.02
1.8
2.6
g/l
4.1
3.9
0.19
25
348
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
328
0.98
0.01
1.6
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
33
338
0.98
0.01
1.5
1.9
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
223
1.03
0.01
1.1
1.1
iu/ml
26.4
89.7
—
7
50
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
307
0.98
0.01
1.2
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
143
1422
1.01
0.01
1.9
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
144
0.97
0.00
1.1
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
122
0.98
0.00
1.9
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
122
0.98
0.00
1.9
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
122
0.98
0.00
1.9
1.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
162
0.99
0.00
1.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
21
212
0.99
0.00
1.3
1.7
g/l
0.6
0.9
0.68
15
165
(3003888) Timothy IgE Ab [Units/volume] in Serum
18
179
1.01
0.00
1.1
1.1
u/ml
14.6
6.2
0.45
12
92
(3023419) Bacteria identified in Sputum by Culture
19
189
1.01
0.00
1.4
2.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
291
1.00
0.00
1.4
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
521
5213
1.00
0.00
5.4
5.6
g/l
35.9
35.4
1.06
495
4888
(3016018) Differential panel - Cerebral spinal fluid
12
123
0.98
0.00
1.4
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
29
295
0.98
0.00
1.4
1.5
—
15.0
—
0
7
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
11.4
—
0
5
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
67
0.90
0.00
1.0
1.4
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
9
0.00
0.00
0.0
2.1
—
0.8
—
0
9
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
12.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
67
0.90
0.00
1.0
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
151
1510
1.00
0.00
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
67
0.90
0.00
1.0
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
59
0.85
0.00
1.8
1.5
u/field
6.8
1.4
—
5
43
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
95
0.95
0.00
1.0
1.5
g/l
0.9
1.0
—
9
95
(3021901) Oxygen saturation in Capillary blood
27
270
1.00
0.00
2.4
3.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
69
1.01
0.00
1.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.1
—
22.1
—
0
7
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
73
0.96
0.00
1.0
1.6
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
77
0.91
0.00
1.3
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
5
58
0.86
0.00
1.0
1.0
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.3
—
720.6
—
0
9
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
20.6
—
0
9
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
86
0.93
0.00
1.1
1.6
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
2.1
—
0
8
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
6.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
54
0.93
0.00
1.0
1.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.1
—
39.0
—
0
7
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
7.2
—
82.0
—
0
5
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
7.3
—
0
8
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
6.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
58
0.86
0.00
1.2
2.1
u/ml
468.2
1302.5
—
5
58
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
68.8
—
0
5
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
7
71
0.99
0.00
1.6
3.3
—
9.1
—
0
55
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.1
—
8.4
—
0
7
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
67
0.90
0.00
1.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_NOISEINNER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_NOISEINNER | 0.93 [0.69, 1.25] | 0.628 |
| Birth year | 0.998 [0.99, 1.01] | 0.64 |
During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 717 females with H8_NOISEINNER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_NOISEINNER | 0.788 [0.72, 0.86] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 1579 out of 10010 males with H8_NOISEINNER died.
Mortality risk
Mortality risk for people of age
years, who have H8_NOISEINNER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.078% | 0.183% |
| 5 | 0.599% | 1.04% |
| 10 | 1.384% | 2.658% |
| 15 | 2.62% | 5.003% |
| 20 | 4.996% | 8.654% |
Relationships between endpoints
↥Index endpoint: H8_NOISEINNER – Noise effects on inner ear
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data